Ingevity Corporation · NYSE:NGVT

Ingevity — Q2 2024 Earnings Presentation

29 slides from Ingevity's earnings presentation, Aug 1, 2024

  1. Slide 1: Second Quarter 2024 Earnings Presentation

    SECOND QUARTER 2024 EARNINGS PRESENTATION August 1, 2024

  2. Slide 2: Use of non-GAAP financial measures and forward-looking statements

    Use of non-GAAP financial measures: This presentation includes certain non‐GAAP financial measures intended to supplement, not substitute for, comparable GAAP measures. Reconciliations of non‐GAAP financial measures to GAAP financial measures are provided within the Appendix to this presentation. In

  3. Slide 3: Agenda

    AGENDA 1 Quarter highlights and updates 2 Performance Chemicals Repositioning 3 Consolidated financial results 4 Segment performance 5 Guidance Q&A 3

  4. Slide 4: Quarter Highlights and Updates

    QUARTER HIGHLIGHTS AND UPDATES Performance Materials delivers 4th straight quarter of 50%+ EBITDA margins, with revenue growth of 9% and EBITDA growth of 28% Advanced Polymer Technologies delivers 20% EBITDA margins with its 3rd consecutive quarter of volume growth Announced necessary steps as part

  5. Slide 5: Termination of Long-Term CTO Contract

    TERMINATION OF LONG-TERM CTO CONTRACT  CTO purchase requirements from Georgia Pacific ceased July 1  Termination payment of $100 million, with one payment of $50 million made on July 1; second payment due by October 15  As a result of the termination, CTO resale activity will cease other than pre

  6. Slide 6: Consolidating All Refining to North Charleston

    CONSOLIDATING ALL REFINING TO NORTH CHARLESTON Consolidating oleo-based refining to North Charleston facility to maximize asset utilization  Aligns manufacturing footprint with revised view on market demand of oleo products and improves cost structure  Entrance into new oleo markets slower than ex

  7. Slide 7: Performance Chemicals Repositioning Strategy

    PERFORMANCE CHEMICALS REPOSITIONING STRATEGY Products/Mix Manufacturing Optimization Other Savings Optimizing physical footprint  Results in reduced exposure to  Termination of long term CTO  Closure of DeRidder, LA site low margin, cyclical end markets  Consolidated remaining CTO based supply a

  8. Slide 8: Second Quarter (Q2) Consolidated Financial Performance

    SECOND QUARTER (Q2) CONSOLIDATED FINANCIAL PERFORMANCE GAAP Net loss of $283.7 million primarily due to Performance Chemicals non-cash goodwill impairment charge of $349.1 million Performance highlights Q2 financials (1) Sales down 19% primarily driven by lower sales in Industrial vs PY $ in million

  9. Slide 9: Q2 2024 Financial Metrics and Highlights

    Q2 2024 FINANCIAL METRICS AND HIGHLIGHTS Net Sales by Product Line Free cash flow (1) $ in millions  Performance Materials Industrial Specialties Road Technologies  FCF of $12 million and Road Technologies Advanced Polymers Technologies 30% Performance Materials includes $26 million become larger

  10. Slide 10: Performance Materials

    PERFORMANCE MATERIALS Q2 Q2 $ % $ IN MILLIONS VS. PRIOR VS. PRIOR 2024 2023 YEAR YEAR Performance highlights Net Sales 157.2 144.6 12.6 8.7% Sales of $157.2 million up 9% benefited from increased pricing and Segment EBITDA 82.2 64.2 18.0 28.0% automotive carbon volume Segment EBITDA Margin 52.3% 44.

  11. Slide 11: Advanced Polymer Technologies

    ADVANCED POLYMER TECHNOLOGIES Q2 Q2 $ % $ IN MILLIONS 2024 2023 VS. PRIOR VS. PRIOR Performance highlights YEAR YEAR Net Sales 47.9 53.2 (5.3) (10.0)% Sales of $47.9 million down 10% as lower pricing offset increased volumes Segment EBITDA 9.8 11.6 (1.8) (15.5)%  Third consecutive quarter of volume

  12. Slide 12: Performance Chemicals

    PERFORMANCE CHEMICALS $ IN MILLIONS Q2 Q2 $ VS. PRIOR % VS. PRIOR Performance highlights 2024 2023 YEAR YEAR Sales of $185.5 million down 35% due primarily to the segment repositioning Net Sales 185.5 284.0 (98.5) (34.7)%  INDUSTRIAL SPECIALTIES: Sales down 61% due to lower volumes driven primarily

  13. Slide 13: 2024 Guidance and Outlook

    2024 GUIDANCE AND OUTLOOK FY Guidance(1) Financial metric FY Guidance 2024 Uncertainties:  Timing and pace of global industrial recovery Revenue $1.40 - $1.50 billion  Geopolitical risks Adj. EBITDA(2) $350 - $360 million  U.S. Presidential election year dynamics Capital expenditures $90– $100 mi

  14. Slide 14: Thank you for your interest in Ingevity

    FOR MORE INFORMATION Investors John E. Nypaver, Jr. (843) 740 - 2002 Media Caroline Monahan (843) 740 - 2068 Thank you for your interest in Ingevity. 14

  15. Slide 15: Appendix

    APPENDIX 15

  16. Slide 16: Definitions of non-GAAP financial measures

    Ingevity has presented certain financial measures, defined below, which have not been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and has provided a reconciliation to the most directly comparable financial measure calculated in accordance with GAAP on the follo

  17. Slide 17: Reconciliation of Net Income and Diluted EPS to Adjusted Earnings

    Reconciliation of Net Income (Loss) (GAAP) and Diluted Earnings (Loss) Per Share (GAAP) to Adjusted Earnings (Loss) (Non-GAAP) and Diluted Adjusted Earnings (Loss) Per Share (Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions, except per data (unaudited) 2024 2023 2024 2023

  18. Slide 18: Restructuring and other (income) charges

    Restructuring and other (income) charges Three Months Ended June 30, Six Months Ended June 30, In millions 2024 2023 2024 2023 Work force reductions and other $ — $ 7.0 $ — $ 10.1 Performance Chemicals' repositioning 10.0 — 72.3 — Restructuring charges (1) $ 10.0 $ 7.0 $ 72.3 $ 10.1 Alternative feed

  19. Slide 19: Acquisition and other-related (income) charges

    Acquisition and other-related (income) charges Three Months Ended June 30, Six Months Ended June 30, In millions 2024 2023 2024 2023 Legal and professional service fees $ (0.2) $ 1.8 $ 0.1 $ 3.7 Acquisition-related (income) costs $ (0.2) $ 1.8 $ 0.1 $ 3.7 (1) Inventory fair value step-up amortizatio

  20. Slide 20: Reconciliation of Net Income and Diluted EPS (revised Q1 2024)

    Reconciliation of Net Income (Loss) (GAAP) and Diluted Earnings (Loss) Per Share (GAAP) to Adjusted Earnings (Loss) (Non-GAAP) and Diluted Adjusted Earnings (Loss) Per Share (Non-GAAP) We revised our March 31, 2024 non-GAAP Adjusted earnings (loss) calculation to remove previous adjustments of $2.5

  21. Slide 21: Reconciliation of Net Income to Adjusted EBITDA

    Reconciliation of Net Income (GAAP) to Adjusted EBITDA (Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions, except percentages (unaudited) 2024 2023 2024 2023 Net income (loss) (GAAP) $ (283.7) $ 35.5 $ (339.7) $ 86.2 Provision (benefit) for income taxes (50.9) 12.2 (66.8) 2

  22. Slide 22: Reconciliation of Net Income to Adjusted EBITDA (revised)

    Reconciliation of Net Income (GAAP) to Adjusted EBITDA (Non-GAAP) We revised our December 31, 2023 and March 31, 2024 non-GAAP Adjusted EBITDA calculation to remove previous adjustments of $19.7 million and $2.5 million, respectively, related to inventory lower of cost or market charges associated w

  23. Slide 23: Reconciliation of Gross Profit to Adjusted Gross Profit

    Reconciliation of Gross Profit (GAAP) to Adjusted Gross Profit (Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions, except percentages (unaudited) 2024 2023 2024 2023 Gross Profit (GAAP) $ 123.2 $ 153.0 $ 222.9 $ 283.4 Plus: Depreciation and amortization 17.3 16.5 34.9 33.8

  24. Slide 24: Reconciliation of SG&A to Adjusted SG&A

    Reconciliation of SG&A (GAAP) to Adjusted SG&A (Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions, except percentages (unaudited) 2024 2023 2024 2023 SG&A (GAAP) $ 41.4 $ 51.7 $ 88.6 $ 100.3 Research and technical expenses (GAAP) 7.3 8.0 14.1 16.8 Total SG&A (GAAP) 48.7 59.

  25. Slide 25: Reconciliation of Other (income) expense, net to Adjusted

    Reconciliation of Other (income) expense, net (GAAP) to Adjusted Other (income) expense, net (Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions, except percentages (unaudited) 2024 2023 2024 2023 Other (income) expense, net (GAAP) $ 23.9 $ 3.0 $ 56.1 $ (15.2) Less: (Gain) l

  26. Slide 26: Reconciliation of Cash Flow from Operations to Free Cash Flow

    Reconciliation of Cash Flow from Operations (GAAP) to Free Cash Flow (Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions (unaudited) 2024 2023 2024 2023 Cash Flow from Operations (GAAP) $ 29.7 $ 48.4 $ 17.6 $ 53.7 Less: Capital Expenditures (GAAP) 18.1 21.7 34.7 47.1 Free Ca

  27. Slide 27: Calculation of Net Debt to Adjusted EBITDA Ratio

    Calculation of Net Debt to Adjusted EBITDA Ratio (Non-GAAP) In millions, except ratios (unaudited) June 30, 2024 Notes payable and current maturities of long-term debt $ 103.0 Long-term debt including finance lease obligations 1,401.0 Debt issuance costs 4.8 Total Debt $ 1,508.8 Less: Cash and cash

  28. Slide 28: Calculation of Net Debt to Adjusted EBITDA Ratio (revised March 2024)

    Calculation of Net Debt to Adjusted EBITDA Ratio (Non-GAAP) We revised our March 31, 2024 non-GAAP Net debt ratio calculation to remove the previous adjustments of $2.5 million from the three months ended March 31, 2024 and $19.7 million from the three months ended December 31, 2023, from the last t

  29. Slide 29: Calculation of Net Debt to Adjusted EBITDA Ratio (revised December 2023)

    Calculation of Net Debt to Adjusted EBITDA Ratio (Non-GAAP) We revised our December 31, 2023 non-GAAP Net debt ratio calculation to remove the previous adjustment of $19.7 million from the three months ended December 31, 2023, from the last twelve months Adjusted EBITDA related to inventory lower of

Ingevity — Q2 2024 Earnings Presentation on 6ix